Xoma | XOMA - Ingresos Por Ventas





Ventas Cambio Fecha
AbbVie USD 15B 1.62B 2026-03
Agenus USD 34.2M 3.97M 2025-12
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Ardelyx USD 94.47M 30.74M 2026-03
aTyr Pharma USD 110.08M 109.89M 2025-12
BioMarin Pharmaceutical USD 766M 109M 2026-03
Celldex Therapeutics USD 15K 106K 2026-03
Curis USD 1.14M 1.41M 2025-12
Eli Lilly USD 19.8B 500M 2026-03
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Incyte USD 1.27B 240M 2026-03
MacroGenics USD 20.8M 20.43M 2026-03
Novartis USD 13.11B 226M 2026-03
Novartis USD 13.11B 750M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Prothena USD 51.08M 51.06M 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Xoma USD 25K 5M 2024-09